The Department of Health said Sunday it would stop the use of combination HIV drug lopinavir and ritonavir in its treatment of hospitalized COVID-19 patients following the World Health Organization’s move.
MANILA – The Department of Health said Sunday it would stop the use of combination HIV drug lopinavir and ritonavir in its treatment of hospitalized COVID-19 patients following the World Health Organization’s move.
The agency had also previously discontinued using anti-malaria drug hydroxychloroquine, according to Health Undersecretary Maria Rosario Vergeire.
